Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2003;12(Supplement 1 ):i14-i24; doi:10.1136/tc.12.suppl_1.i14
Copyright © 2003 by the BMJ Publishing Group Ltd.
Tobacco Control 2003;12:i14
© 2003 BMJ Publishing Group

Article

Regulatory strategies to reduce tobacco addiction in youth

J E Henningfield1, E T Moolchan2, M Zeller3

1 Johns Hopkins University School of Medicine, Pinney Associates, Bethesda, Maryland, USA
2 Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA
3 Pinney Associates, Bethesda, Maryland, USA

Correspondence to:
Correspondence to:
Jack E Henningfield, PhD, Pinney Associates, 4800 Montgomery Lane, Suite 1000, Bethesda, MD 20814, USA;
jhenning{at}pinneyassociates.com

ABSTRACT

Preventing tobacco addiction and achieving cessation in established users are the cornerstones of efforts to reduce tobacco use and disease. It has been increasingly recognised that reducing tobacco toxin exposure has theoretical potential to reduce disease in continuing tobacco users. This has been controversial because such approaches also carry the potential to undermine prevention and cessation. As complicated as harm reduction issues are for adults, they are still more complicated for youth. Harm reduction is not a singular approach, but rather a concept that encompasses an extremely diverse array of potential approaches. These carry equally diverse potential risks and benefits. The regulatory framework (for example, whether or not the Food and Drug Administration regulates the approach) is also predicted to be a major factor in determining the consequences of harm reduction approaches. This paper examines the various issues and potential approaches concerning the application of harm reduction to youth. We conclude that although some carry great risk, others may actually support broader tobacco control efforts to prevent tobacco use and foster cessation in youth and adults.

Keywords: adolescence; youth; nicotine addiction; regulatory strategies; harm reduction

Abbreviations: AMA, American Medical Association; FDA, Food and Drug Administration; FTC, Federal Trade Commission; IOM, Institute of Medicine; PREPs, potential reduced exposure products


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Flory, J. D., Manuck, S. B. (2009). Impulsiveness and Cigarette Smoking. Psychosom. Med. 71: 431-437 [Abstract] [Full Text]  
  • Henningfield, J E, Benowitz, N L, Connolly, G N, Davis, R M, Gray, N, Myers, M L, Zeller, M (2004). Reducing tobacco addiction through tobacco product regulation. Tobacco Control 13: 132-135 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.